USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: APPLIED GENETIC TECHNOLOGIES CORPORATION
Address: APPLIED GENETIC TECHNOLOGIES CRP
12085 RESEARCH DR, STE 110
ALACHUA, FL 32615-0683
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (386) 462-2204

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $531,518.00 3

Award List:

TREATMENT OF ANEMIA USING AAV VECTORS

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark C. Walker
Award Amount: $256,725.00
Abstract:
DESCRIPTION (applicant's abstract): The innovative use of AAV vector technology is proposed to develop milestones essential for the safe treatment of anemia secondary to chronic renal failure in cats. An A.AV-FeEPO vector has been constructed. The initial, in vitro, study… More

Molecular Breeding of Gene Therapy Vectors

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kyukye Hwang
Award Amount: $131,711.00
Abstract:
DESCRIPTION (provided by applicant): We propose to develop Gene Therapy vectors that are targeted to particular cell membrane receptors, cell types and/or tissues. Development of these precise delivery systems will help overcome potential adverse reactions and high dosing requirements imposed by the… More

rAAV5-hCNGB3 Gene Therapy for Achromatopsia: Efficacy in a Dog Model

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jeffrey D. Chulay
Award Amount: $143,082.00
Abstract:
DESCRIPTION (provided by applicant): Complete achromatopsia is an inherited retinal disorder characterized by severely reduced visual acuity, nystagmus, severe photophobia, a small central scotoma, eccentric fixation, and complete loss of color discrimina tion. In 50% of patients with achromatopsia… More